1 recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Continuous Renal Replacement Therapy (CRRT): new trials by email Literature Review of Continuous Renal Replacement Therapy (CRRT) trials Research Report on Continuous Renal Replacement Therapy (CRRT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory - Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) | Phase 3 | Recruiting | Vantive Health LLC | 40 | 2024-07-12 | 2026-10-05 |
| Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT) Prismocitrate 18, No Anticoagulation - Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) | Phase 3 | Terminated | Vantive Health LLC | 34 | 2016-09-27 | 2025-07-22 |
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2)
United States (2) · Canada (1)